eFFECTOR Therapeutics, Inc. (EFTR) PT Lowered to $10 at Stifel
Tweet Send to a Friend
Stifel analyst Benjamin J. Burnett lowered the price target on eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) to $10.00 (from $21.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
